Revelation Biosciences Inc (REVB) — Free Cash Flow Generation Index
Revelation Biosciences Inc (REVB) has a Free Cash Flow Generation Index of 1.04x as of December 2018. Free cash flow of $8.78 Million represents 1% of operating cash flow ($8.43 Million). See REVB working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Revelation Biosciences Inc Free Cash Flow Generation Index (2015–2019)
Historical FCF Generation Index trend for Revelation Biosciences Inc across 5 annual periods. Explore Revelation Biosciences Inc (REVB) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Revelation Biosciences Inc (2015–2019)
Year-by-year Free Cash Flow Generation Index for Revelation Biosciences Inc. For the full company profile including market capitalisation, see REVB stock market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2019 | 1.01x | $41.61 Million | $41.09 Million | $526.00K | ▼ -1.3% |
| 2018 | 1.03x | $33.44 Million | $32.58 Million | $861.00K | ▼ -0.7% |
| 2017 | 1.03x | $25.05 Million | $24.25 Million | $804.00K | ▼ -1.6% |
| 2016 | 1.05x | $12.18 Million | $11.60 Million | $582.00K | ▲ +0.0% |
| 2015 | 1.05x | $12.18 Million | $11.60 Million | $582.00K | — |